Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs MUB✓SelectedUSD · MUBGSK vs MUB performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs MUB

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+40.3%
MUB return
+2.0%
Excess return
+38.3%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMUBExcessAlpha
1D-1.6%0.0%-1.5%-1.5%
7D-4.7%-0.8%-3.9%-3.9%
30D-4.7%+1.0%-5.7%-5.7%
3M-8.8%-1.6%-7.1%-6.9%
6M-4.6%-0.8%-3.8%-3.6%
YTD+1.0%-1.1%+2.1%+2.6%
1Y+6.9%-0.5%+7.4%+7.9%
3Y+52.5%+8.0%+44.6%+43.2%
5Y+40.3%+2.0%+38.3%+14.5%
All+40.3%+2.0%+38.3%+14.5%

Cumulative growth

Daily Returns

Daily percentage return beside MUB.

Daily Out/Under-Performance

Portfolio return minus MUB return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MUB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MUB wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling